CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 10.94
  • +0.19+1.77%
Market Closed Jun 26 15:00 CST
4.49BMarket Cap28.49P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
25.62%561.77M
32.83%560.17M
85.94%661.7M
42.85%589.85M
143.16%447.19M
43.67%421.71M
--355.86M
135.17%412.93M
--183.91M
-44.00%293.52M
Transactional financial assets
-23.88%566.22M
-19.40%637.72M
-36.45%526.87M
-28.37%621.43M
211.46%743.85M
284.48%791.24M
--829.05M
144.97%867.57M
--238.82M
--205.8M
Notes receivable and accounts receivable
43.66%319.02M
45.26%269.39M
47.67%281.44M
31.90%245.99M
44.33%222.07M
56.41%185.45M
--190.59M
56.65%186.49M
--153.87M
30.76%118.57M
-Notes receivable
----
----
----
----
----
--236.8K
--236.8K
----
----
----
-Accounts receivable
43.66%319.02M
45.45%269.39M
47.85%281.44M
31.90%245.99M
44.33%222.07M
56.21%185.22M
--190.36M
56.65%186.49M
--153.87M
30.76%118.57M
Other receivables (including interest and dividends)
8.30%5.61M
67.73%6.09M
51.71%5.42M
-87.15%5.31M
-86.48%5.18M
-90.85%3.63M
--3.57M
4,406.92%41.33M
--38.34M
3,338.55%39.68M
-Accrued interest receivable
----
----
----
----
----
----
----
--254.03K
--776.89K
--396.89K
-Other receivable
----
67.73%6.09M
----
-87.08%5.31M
----
-90.76%3.63M
----
4,379.22%41.08M
----
3,304.16%39.28M
Advance payment
20.09%6.21M
40.40%3.92M
318.60%7.26M
236.45%6.37M
88.61%5.17M
42.73%2.79M
--1.73M
-6.25%1.89M
--2.74M
16.97%1.95M
Inventories
8.97%54.37M
-4.81%47.09M
12.38%52.35M
17.70%48.23M
35.46%49.89M
64.44%49.47M
--46.59M
88.88%40.98M
--36.83M
73.67%30.08M
Non-current assets due within one year
271.63%120.05M
--120.1M
--76.58M
--75.92M
--32.3M
----
----
----
----
----
Other current assets
225.19%14.85M
2.51%13.04M
53.71%15.65M
-40.26%6.75M
-74.18%4.57M
-26.56%12.72M
--10.18M
-13.37%11.29M
--17.69M
41.41%17.32M
Adjustment items of current assets
----
----
----
----
--0.01
----
----
----
----
----
Total current assets
9.13%1.65B
12.99%1.66B
13.20%1.63B
2.39%1.6B
124.67%1.51B
107.52%1.47B
--1.44B
127.62%1.56B
--672.19M
9.22%706.93M
Non Current assets
Debt investment
--3.03M
----
----
----
----
----
----
----
----
----
Other equity investment
--500K
--500K
----
----
----
----
----
----
----
----
Fixed assets
----
150.77%486.7M
----
5.21%194.17M
----
10.30%194.08M
----
10.95%184.56M
----
10.29%175.96M
Constru in process
----
-47.80%89.6M
----
106.82%231.84M
----
223.81%171.67M
----
1,646.50%112.1M
----
1,728.91%53.02M
Productive biological assets
67.36%7.47M
53.91%5.98M
70.18%7.25M
12.03%5.13M
-5.19%4.46M
3.26%3.88M
--4.26M
28.53%4.58M
--4.71M
432.34%3.76M
Intangible assets
-0.92%47.83M
-2.42%47.34M
-2.39%47.47M
-3.79%47.36M
-2.97%48.27M
-2.06%48.51M
--48.63M
19.00%49.23M
--49.75M
20.23%49.53M
Long deferred expense
96.90%34.05M
90.14%36.68M
-26.97%14.99M
-29.68%15.62M
-26.88%17.29M
-21.66%19.29M
--20.53M
-1.53%22.21M
--23.65M
3.36%24.63M
Deferred tax assets
109.56%36.49M
86.86%31.85M
221.10%19.86M
145.00%18.48M
242.00%17.41M
254.75%17.05M
--6.18M
26.70%7.54M
--5.09M
-15.58%4.81M
Usufruct assets
5.91%44.46M
673.06%42.62M
985.16%41.5M
842.09%40.31M
791.31%41.98M
12,998.32%5.51M
--3.82M
--4.28M
--4.71M
--42.09K
Other non current assets
-67.00%75.97M
-57.55%109.6M
-35.75%186.94M
-10.36%178.5M
4,363.93%230.2M
4,458.14%258.17M
--290.98M
5,898.44%199.15M
--5.16M
171.84%5.66M
Adjustment items of non current assets
----
--0.01
--0.01
----
----
----
----
----
----
----
Total non current assets
12.00%911.32M
16.95%920.07M
11.75%850.82M
30.47%800.46M
116.98%813.67M
126.40%786.71M
--761.38M
145.89%613.53M
--375M
47.27%347.48M
Total assets
10.14%2.56B
14.37%2.58B
12.69%2.48B
10.31%2.4B
121.92%2.32B
113.74%2.25B
122.11%2.2B
132.49%2.18B
--1.05B
19.39%1.05B
Liabilities
Current liabilities
Short term loan
165.46%85.15M
523.92%76.16M
7,074.11%77.04M
4,212.35%47.17M
2,816.97%32.08M
136.88%12.21M
--1.07M
-87.90%1.09M
--1.1M
2.70%5.15M
Notes payable and accounts payable
84.53%89.47M
100.56%101.86M
-4.24%64.08M
-32.99%57.03M
-10.37%48.49M
-17.73%50.79M
--66.92M
43.65%85.1M
--54.1M
33.30%61.73M
-Accounts payable
84.53%89.47M
100.56%101.86M
-4.24%64.08M
-32.99%57.03M
-10.37%48.49M
-17.73%50.79M
--66.92M
56.90%85.1M
--54.1M
49.44%61.73M
Contract liabilities
16.28%103.06M
21.61%108.42M
29.99%98.51M
15.87%89.17M
16.78%88.63M
17.45%89.15M
--75.78M
38.84%76.95M
--75.9M
26.52%75.91M
Salaries payable
-7.46%27.92M
2.75%43.68M
11.82%44.68M
20.78%36.65M
26.21%30.17M
25.12%42.51M
--39.96M
44.16%30.34M
--23.91M
66.99%33.97M
Taxs payable
115.59%15.18M
146.68%16.66M
-29.21%6.3M
-63.30%4.72M
45.20%7.04M
-25.81%6.76M
--8.9M
65.44%12.87M
--4.85M
-24.34%9.11M
Other payable (including interest and dividends)
2.52%9.5M
2.55%10.24M
-9.34%8.34M
317.28%27.23M
42.54%9.27M
72.49%9.98M
--9.2M
61.29%6.53M
--6.5M
8.54%5.79M
-Dividend payable
----
----
----
--16.81M
----
----
----
----
----
----
-Other payable
----
2.55%10.24M
----
59.69%10.42M
----
72.49%9.98M
----
61.29%6.53M
----
8.54%5.79M
Non current liabilities due within one year
88.50%10.48M
259.77%9.4M
--8.68M
--6.4M
--5.56M
--2.61M
----
----
----
----
Other current liabilities
----
----
----
----
----
-16.93%68K
----
----
----
-81.11%81.85K
Adjustment items of current assets
--0.01
--0.01
----
----
----
----
----
----
--0.01
----
Total current liabilities
54.03%340.77M
71.16%366.41M
52.42%307.64M
26.06%268.36M
33.00%221.24M
11.65%214.07M
--201.84M
35.81%212.88M
--166.35M
28.28%191.74M
Current liabilities
Deferred tax liabilities
-5.45%9.72M
-4.96%9.41M
59.16%11.8M
39.05%10.44M
51.37%10.28M
52.25%9.9M
--7.41M
26.23%7.51M
--6.79M
6.94%6.5M
Long term deferred income
-11.13%39.37M
-16.21%41.04M
-11.56%39.62M
-24.92%41.96M
-11.29%44.3M
-2.97%48.99M
--44.8M
-15.43%55.89M
--49.95M
-28.29%50.49M
Lease liabilities
2.29%38.34M
1,083.92%36.07M
731.35%36.14M
597.40%36.56M
623.14%37.48M
12,346.02%3.05M
--4.35M
--5.24M
--5.18M
--24.48K
Total non current liabilities
-5.03%87.43M
39.71%86.52M
54.80%87.56M
27.74%88.96M
41.80%92.07M
-19.61%61.93M
--56.56M
-3.32%69.65M
--64.93M
0.73%77.04M
Total liabilities
36.67%428.2M
64.10%452.93M
52.94%395.2M
26.47%357.33M
35.47%313.31M
2.69%276M
6.01%258.4M
23.49%282.53M
--231.28M
18.95%268.78M
Shareholders equity
Paid-in capital
0.00%410M
0.00%410M
0.00%410M
0.00%410M
13.89%410M
13.89%410M
--410M
13.89%410M
--360M
0.00%360M
Capital reserve funds
0.28%1.26B
0.37%1.26B
0.36%1.26B
0.38%1.26B
353.70%1.26B
352.97%1.25B
--1.25B
352.73%1.25B
--276.73M
1.12%276.73M
Surplus reserve funds
34.78%43.55M
34.78%43.55M
71.96%32.31M
71.96%32.31M
64.00%32.31M
71.96%32.31M
--18.79M
317.24%18.79M
--19.7M
317.24%18.79M
Retained profit
41.45%441.33M
46.57%411.85M
48.03%381.87M
61.59%341.72M
95.92%312.02M
116.40%280.99M
--257.97M
222.65%211.48M
--159.26M
576.14%129.84M
Less:Treasury stock
--23.87M
----
----
----
----
----
----
----
----
----
Other composite income
58.25%1.16M
19.44%1.09M
36.48%1.31M
260.27%1.4M
221.31%732.68K
239.48%908.76K
--958.09K
-3.82%387.49K
--228.03K
322.45%267.69K
Shareholders equity without minority interests
6.00%2.13B
7.43%2.12B
7.34%2.08B
7.89%2.04B
146.42%2.01B
151.74%1.98B
160.03%1.94B
167.75%1.89B
--815.92M
19.53%785.63M
Total shareholder equity
6.00%2.13B
7.43%2.12B
7.34%2.08B
7.89%2.04B
146.42%2.01B
151.74%1.98B
160.03%1.94B
167.75%1.89B
--815.92M
19.53%785.63M
Adjustment items of liabilities and equity
----
----
--0.01
----
----
----
----
----
----
----
Total liabilityies and equity
10.14%2.56B
14.37%2.58B
12.69%2.48B
10.31%2.4B
121.92%2.32B
113.74%2.25B
122.11%2.2B
132.49%2.18B
--1.05B
19.39%1.05B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 25.62%561.77M32.83%560.17M85.94%661.7M42.85%589.85M143.16%447.19M43.67%421.71M--355.86M135.17%412.93M--183.91M-44.00%293.52M
Transactional financial assets -23.88%566.22M-19.40%637.72M-36.45%526.87M-28.37%621.43M211.46%743.85M284.48%791.24M--829.05M144.97%867.57M--238.82M--205.8M
Notes receivable and accounts receivable 43.66%319.02M45.26%269.39M47.67%281.44M31.90%245.99M44.33%222.07M56.41%185.45M--190.59M56.65%186.49M--153.87M30.76%118.57M
-Notes receivable ----------------------236.8K--236.8K------------
-Accounts receivable 43.66%319.02M45.45%269.39M47.85%281.44M31.90%245.99M44.33%222.07M56.21%185.22M--190.36M56.65%186.49M--153.87M30.76%118.57M
Other receivables (including interest and dividends) 8.30%5.61M67.73%6.09M51.71%5.42M-87.15%5.31M-86.48%5.18M-90.85%3.63M--3.57M4,406.92%41.33M--38.34M3,338.55%39.68M
-Accrued interest receivable ------------------------------254.03K--776.89K--396.89K
-Other receivable ----67.73%6.09M-----87.08%5.31M-----90.76%3.63M----4,379.22%41.08M----3,304.16%39.28M
Advance payment 20.09%6.21M40.40%3.92M318.60%7.26M236.45%6.37M88.61%5.17M42.73%2.79M--1.73M-6.25%1.89M--2.74M16.97%1.95M
Inventories 8.97%54.37M-4.81%47.09M12.38%52.35M17.70%48.23M35.46%49.89M64.44%49.47M--46.59M88.88%40.98M--36.83M73.67%30.08M
Non-current assets due within one year 271.63%120.05M--120.1M--76.58M--75.92M--32.3M--------------------
Other current assets 225.19%14.85M2.51%13.04M53.71%15.65M-40.26%6.75M-74.18%4.57M-26.56%12.72M--10.18M-13.37%11.29M--17.69M41.41%17.32M
Adjustment items of current assets ------------------0.01--------------------
Total current assets 9.13%1.65B12.99%1.66B13.20%1.63B2.39%1.6B124.67%1.51B107.52%1.47B--1.44B127.62%1.56B--672.19M9.22%706.93M
Non Current assets
Debt investment --3.03M------------------------------------
Other equity investment --500K--500K--------------------------------
Fixed assets ----150.77%486.7M----5.21%194.17M----10.30%194.08M----10.95%184.56M----10.29%175.96M
Constru in process -----47.80%89.6M----106.82%231.84M----223.81%171.67M----1,646.50%112.1M----1,728.91%53.02M
Productive biological assets 67.36%7.47M53.91%5.98M70.18%7.25M12.03%5.13M-5.19%4.46M3.26%3.88M--4.26M28.53%4.58M--4.71M432.34%3.76M
Intangible assets -0.92%47.83M-2.42%47.34M-2.39%47.47M-3.79%47.36M-2.97%48.27M-2.06%48.51M--48.63M19.00%49.23M--49.75M20.23%49.53M
Long deferred expense 96.90%34.05M90.14%36.68M-26.97%14.99M-29.68%15.62M-26.88%17.29M-21.66%19.29M--20.53M-1.53%22.21M--23.65M3.36%24.63M
Deferred tax assets 109.56%36.49M86.86%31.85M221.10%19.86M145.00%18.48M242.00%17.41M254.75%17.05M--6.18M26.70%7.54M--5.09M-15.58%4.81M
Usufruct assets 5.91%44.46M673.06%42.62M985.16%41.5M842.09%40.31M791.31%41.98M12,998.32%5.51M--3.82M--4.28M--4.71M--42.09K
Other non current assets -67.00%75.97M-57.55%109.6M-35.75%186.94M-10.36%178.5M4,363.93%230.2M4,458.14%258.17M--290.98M5,898.44%199.15M--5.16M171.84%5.66M
Adjustment items of non current assets ------0.01--0.01----------------------------
Total non current assets 12.00%911.32M16.95%920.07M11.75%850.82M30.47%800.46M116.98%813.67M126.40%786.71M--761.38M145.89%613.53M--375M47.27%347.48M
Total assets 10.14%2.56B14.37%2.58B12.69%2.48B10.31%2.4B121.92%2.32B113.74%2.25B122.11%2.2B132.49%2.18B--1.05B19.39%1.05B
Liabilities
Current liabilities
Short term loan 165.46%85.15M523.92%76.16M7,074.11%77.04M4,212.35%47.17M2,816.97%32.08M136.88%12.21M--1.07M-87.90%1.09M--1.1M2.70%5.15M
Notes payable and accounts payable 84.53%89.47M100.56%101.86M-4.24%64.08M-32.99%57.03M-10.37%48.49M-17.73%50.79M--66.92M43.65%85.1M--54.1M33.30%61.73M
-Accounts payable 84.53%89.47M100.56%101.86M-4.24%64.08M-32.99%57.03M-10.37%48.49M-17.73%50.79M--66.92M56.90%85.1M--54.1M49.44%61.73M
Contract liabilities 16.28%103.06M21.61%108.42M29.99%98.51M15.87%89.17M16.78%88.63M17.45%89.15M--75.78M38.84%76.95M--75.9M26.52%75.91M
Salaries payable -7.46%27.92M2.75%43.68M11.82%44.68M20.78%36.65M26.21%30.17M25.12%42.51M--39.96M44.16%30.34M--23.91M66.99%33.97M
Taxs payable 115.59%15.18M146.68%16.66M-29.21%6.3M-63.30%4.72M45.20%7.04M-25.81%6.76M--8.9M65.44%12.87M--4.85M-24.34%9.11M
Other payable (including interest and dividends) 2.52%9.5M2.55%10.24M-9.34%8.34M317.28%27.23M42.54%9.27M72.49%9.98M--9.2M61.29%6.53M--6.5M8.54%5.79M
-Dividend payable --------------16.81M------------------------
-Other payable ----2.55%10.24M----59.69%10.42M----72.49%9.98M----61.29%6.53M----8.54%5.79M
Non current liabilities due within one year 88.50%10.48M259.77%9.4M--8.68M--6.4M--5.56M--2.61M----------------
Other current liabilities ---------------------16.93%68K-------------81.11%81.85K
Adjustment items of current assets --0.01--0.01--------------------------0.01----
Total current liabilities 54.03%340.77M71.16%366.41M52.42%307.64M26.06%268.36M33.00%221.24M11.65%214.07M--201.84M35.81%212.88M--166.35M28.28%191.74M
Current liabilities
Deferred tax liabilities -5.45%9.72M-4.96%9.41M59.16%11.8M39.05%10.44M51.37%10.28M52.25%9.9M--7.41M26.23%7.51M--6.79M6.94%6.5M
Long term deferred income -11.13%39.37M-16.21%41.04M-11.56%39.62M-24.92%41.96M-11.29%44.3M-2.97%48.99M--44.8M-15.43%55.89M--49.95M-28.29%50.49M
Lease liabilities 2.29%38.34M1,083.92%36.07M731.35%36.14M597.40%36.56M623.14%37.48M12,346.02%3.05M--4.35M--5.24M--5.18M--24.48K
Total non current liabilities -5.03%87.43M39.71%86.52M54.80%87.56M27.74%88.96M41.80%92.07M-19.61%61.93M--56.56M-3.32%69.65M--64.93M0.73%77.04M
Total liabilities 36.67%428.2M64.10%452.93M52.94%395.2M26.47%357.33M35.47%313.31M2.69%276M6.01%258.4M23.49%282.53M--231.28M18.95%268.78M
Shareholders equity
Paid-in capital 0.00%410M0.00%410M0.00%410M0.00%410M13.89%410M13.89%410M--410M13.89%410M--360M0.00%360M
Capital reserve funds 0.28%1.26B0.37%1.26B0.36%1.26B0.38%1.26B353.70%1.26B352.97%1.25B--1.25B352.73%1.25B--276.73M1.12%276.73M
Surplus reserve funds 34.78%43.55M34.78%43.55M71.96%32.31M71.96%32.31M64.00%32.31M71.96%32.31M--18.79M317.24%18.79M--19.7M317.24%18.79M
Retained profit 41.45%441.33M46.57%411.85M48.03%381.87M61.59%341.72M95.92%312.02M116.40%280.99M--257.97M222.65%211.48M--159.26M576.14%129.84M
Less:Treasury stock --23.87M------------------------------------
Other composite income 58.25%1.16M19.44%1.09M36.48%1.31M260.27%1.4M221.31%732.68K239.48%908.76K--958.09K-3.82%387.49K--228.03K322.45%267.69K
Shareholders equity without minority interests 6.00%2.13B7.43%2.12B7.34%2.08B7.89%2.04B146.42%2.01B151.74%1.98B160.03%1.94B167.75%1.89B--815.92M19.53%785.63M
Total shareholder equity 6.00%2.13B7.43%2.12B7.34%2.08B7.89%2.04B146.42%2.01B151.74%1.98B160.03%1.94B167.75%1.89B--815.92M19.53%785.63M
Adjustment items of liabilities and equity ----------0.01----------------------------
Total liabilityies and equity 10.14%2.56B14.37%2.58B12.69%2.48B10.31%2.4B121.92%2.32B113.74%2.25B122.11%2.2B132.49%2.18B--1.05B19.39%1.05B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg